Joanne M. Foody - Mar 14, 2022 Form 4 Insider Report for Esperion Therapeutics, Inc. (ESPR)

Role: Chief Medical Officer
Signature: /s/ Richard B. Bartram, by power of attorney
Stock symbol: ESPR
Transactions as of: Mar 14, 2022
Transactions value $: $0
Form type: 4
Date filed: 3/16/2022, 05:10 PM
Previous filing: Nov 1, 2021
Next filing: Jun 9, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ESPR	Common Stock	Award	$0	+28K	+32.95%	$0.00	113K	Mar 14, 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	ESPR	Stock Option (right to buy						119K	Mar 14, 2022	Common Stock	119K	$4.74	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Such award will vest over a four (4) year period as follows: 25% shall vest on the one year anniversary of March 15, 2022 and the remainder shall vest in equal quarterly installments over the three (3) year period thereafter, subject to continued service.